Skip to content
naulon

Not checkedNot checked for notices yet.

Molecular analysis of multifocal prostate cancer cases

Rasa SABALIAUSKAITĖ, Donatas PETROŠKA, Darius DASEVIČIUS and 4 more

Acta Medica Lituanica · 2011

doi:10.6001/actamedica.v18i4.1867 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background. Prostate cancer (PCa) is usually a multifocal disease with different foci displaying histological and molecular heterogeneity. Biopsy-based pathology diagnosis of PCa may not be representative of the entire tumour; thus, markers more precisely characterizing every focus of multifocal PCa are highly instrumental for a better testing of PCa. Materials and Methods. Two distant foci of prostate adenocarcinoma were obtained from prostatectomy specimens of ten patients with pT2–pT3 stage PCa. The expression of TMPRSS2: ERG, TMPRSS2: ETV1, and TERT was assessed by means of reverse transcription PCR and quantified using the real-time-based approach. Ki-67, ERG, EMA, AMACR, p16, and p53 expression was evaluated by means of immunohistochemistry (IHC) on tissue microarrays (TMA). Results. Two out of ten cases were identified with different Gleason scores in paired foci of PCa. The expression of most of the IHC markers was quite even between TMA cores of each PCa case, with p16 showing the highest level of heterogeneity (44%; 4/9); 80% (8/10) of multifocal PCa expressed different variants of the TMPRSS2: ERG transcript or showed a varying status of fusion positivity in paired foci, and the expression levels of the transcript were also heterogeneous. Similarly, 90% (9/10) of PCa showed a different positivity for TERT expression in paired foci. Conclusions. Measurement of TMPRSS2: ERG and TERT expression offers a valuable tool for identifying most aggressive tumour foci and selecting a relevant treatment of PCa. Keywords: prostate cancer, multifocality, TMPRSS2: ERG, telomerase

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.